6-Jan-2025
No headlines found.
PRNewswire (Mon, 23-Dec 9:00 AM ET)
Fresenius Medical Care returns to Dax 40 Index
PRNewswire (Fri, 20-Dec 11:23 AM ET)
PRNewswire (Tue, 19-Nov 9:00 AM ET)
Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024
PRNewswire (Tue, 5-Nov 7:00 AM ET)
PRNewswire (Mon, 21-Oct 11:04 AM ET)
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) trades on the NYSE stock market under the symbol FMS.
As of January 6, 2025, FMS stock price climbed to $22.80 with 180,225 million shares trading.
FMS has a beta of 0.48, meaning it tends to be less sensitive to market movements. FMS has a correlation of 0.04 to the broad based SPY ETF.
FMS has a market cap of $13.38 billion. This is considered a Large Cap stock.
Last quarter Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) reported $5 billion in Revenue and $.45 earnings per share. This fell short of revenue expectation by $-88 million and exceeded earnings estimates by $.07.
In the last 3 years, FMS traded as high as $35.04 and as low as $12.79.
The top ETF exchange traded funds that FMS belongs to (by Net Assets): APIE, AVDE, CVAR, IDVZ, AVSD.
FMS has underperformed the market in the last year with a return of +13.9%, while SPY returned +28.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in FMS shares. However, FMS has outperformed the market in the last 3 month and 2 week periods, returning +10.1% and +0.5%, while SPY returned +4.2% and +0.1%, respectively. This indicates FMS has been having a stronger performance recently.
FMS support price is $22.08 and resistance is $22.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FMS shares will trade within this expected range on the day.